Antibacterial Activity of Twenty Iranian Plant Extracts Against Clinical Isolates of Helicobacter pylori

Document Type: Original Article

Authors

1 Department of Biology and Microbiology, Faculty of Sciences, Alzahra University, Tehran, Iran

2 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, G.C., Tehran, Iran

3 Department of Chemistry, Faculty of Sciences, Shahid Beheshti University, G.C., Tehran, Iran

4 Digestive Diseases Research Center, Faculty of Medical Sciences, Tehran University, Tehran, Iran

Abstract

Objective(s)
Due to increasing emergence of drug-resistance in Helicobacter pylori isolates, traditional plants are potentially valuable sources of novel anti-H. pylori agents. In this research, anti-H. pylori activity of the organic extracts of twenty native Iranian plants was determined against ten clinical isolates of H. pylori. Materials and Methods
Disc diffusion was used to determine the biological activity of 20 plant extracts as well as 8 antibiotics commonly used to treat H. pylori infections. Minimum inhibitory concentrations were also measured by tube and agar dilution methods for the biologically active plant extracts.
Results
Of the twenty plant extracts analyzed, sixteen exhibited good anti-H. pylori activity, using disc diffusion. The ten most active extracts were Carum bulbocastanum, Carum carvi, Mentha longifolia, Saliva limbata, Saliva sclarea, Ziziphora clinopodioides, Thymus caramanicus, Glycyrrhiza glabra, Xanthium brasilicum and Trachyspermum copticum. Minimum inhibitory concentrations measured for the 10 biologically active plant extracts were within the range of 31.25 to 500 ^g/ml.
Conclusion
Among the ten plant extracts effective against H. pylori clinical isolates, Carum carvi, Xanthium brasilicum and Trachyspermum copticum showed the highest activity.

Keywords


1.Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology 1997; 113:9183-9191.

2.Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-1315.

3.International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France: World Health Organization; 1994.p.61

4.Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GL, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1127-1131.

5.Graham DY, Qureshi WA. Antibiotic resistant Helicobacter pylori infection and its treatment. Curr Pharm Des 2000; 6:1537-1544.

6.O’Morain C, Montague S. Challenges to therapy in the future. Helicobacter 2000; 5:23-26.

7.Megraud F. Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther 1997; 11: 43-53.

8.Adamak RJ, Suerbaum S, Plaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxicillin-influence on treatment outcome. Am J Gastroenterol 1998; 93:386-389.

9.Falsafi T, Mobasheri F, Nariman F, Najafi M. Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran. J Clin Microbiol 2004; 42:387-389.

10.Li Y, Xu C, Zhang Q, Liu JY, Tan RX. In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. J Ethnopharmacol 2005; 98:329-333.

11.Ohta R, Yamada N, Kaneko H, Ishikawa K, Fukuda H, Fujino T, et al. In vitro inhibition of the growth of Helicobacter pylori by oil-macerated garlic constituents. Antimicrob Agents Chemother 1999; 43:1811-1812.

12.Ingolfsdottir K, Hjalmarspottir M, Slgurdsson A, Gudjonscottir G, Brynjolfsdottir A. In vitro susceptibility of Helicobacter pylori to proto-lichenistic acid from the lichen Certaria islandica. Antimicrob Agents Chemother 1997; 41:215-217.

13.Yee YK, Wing-Leungkoo M. Anti Helicobacter pylori activity of Chinese tea: An in vitro study. Aliment Pharmacol Ther 2000; 4:635-638.

14.Nariman F, Eftekhar F, Habibi Z, Falsafi T. Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter 2004; 9:146-151.

15.Mozaffarian V. Dictionary of Iranian plant names. Farhang Moaser, 1996.

16.DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett LJ, Guerrant RL. Metronidazol susceptibility testing for H. pylori: Comparison of disk, broth and agar dilution methods and their clinical relevance. J Clin Microbiol 1993; 31:1971-1974.

17.Eftekhar F, Nariman F, Habibi Z and Mohammadi N. Antibacterial activity of aerial extracts from Xanthium brasilicum. Iran J Pharm Res 2007; 6:65-68.

18.Sato Y, Oketani H, Yamada T, Singyouchi K, Ohtsubo T, Kihara M, et al. A xanthanolide with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. J Pharmacol 1997; 49:1042-1047.

19.Kim YS, Kim JS, Park SH, Choi HU, Lee CO, Kim SK, et al. Two cytotoxic sesquiterpene lactones from the leaves of Xanthium strumarium and their in vitro inhibitory activity of n-farnesyltransferase. Planta Med 2003; 69:375-377.

20.Favier LS, Maria AOM, Wendel GH,. Borkowskia EJ, Giordano OS, Pelzerb L, et al. Anti-ulcerogenic activity of xanthanolide sesquiterpenes from Xanthium cavanillesii in rats. J Ethnopharmacol 2005;100:260-267.

21. Mahady GB, Pendland SL, Stoia A, Hamill FA, Fabricant D, Dietz BM, et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 2005;19:988-991.

22.Nostro A, Cellini L, Di Bartolomeo S, Di Campli E, Grande R, Cannatelli MA, et al. Antibacterial effect of plant extracts against Helicobacter pylori. Phytother Res 2005; 19:198-202.

23.Deriu A, Branca G, Molicotti P, Pintore G, Chessa M, Tirillini B, et al. In vitro activity of essential oil of Myrtus communis L. against Helicobacter pylori. Int J Antimicrob Agents 2007; 30:562-565.

24.Yeilada E, Gurbuz I, Shibata H. Screening of Turkish anti-ulcerogenic folk remedies for anti-Helicobacter pylori activity. J Ethnopharmacol 1999; 66:289-293.

25.Wang YC, Huang TL. Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immun Med Microbiol 2005; 43:295-300.

26.Stamatis G, Kyriazopoulos P, Golegou S, Basayiannis A, Skaltsas S, Skaltsa H. In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J Ethnopharmacol 2003; 88:175-179.

27.Gurbuz I, Ustun, O, Yesilada E, Sezik E, Kutsal O. Anti-ulcerogenic activity of some plants used as folk remedy in Turkey. J Ethnopharmacol 2003; 88: 93-97.

28.Azuma K, Ito H, Ippoushi K, Higashio H. In vitro antibacterial activity of extracts from four Labiatae herbs against Helicobacter pylori and Streptococcus mutans. Bull Natl Inst Veg & Tea Science, Japan 2003; 2:83-91. 

29.Fukai T, Marumo A, Kaitou K, KandaT, Terada S, Nomura T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 2002; 71:1449-1463.

30.Graham DY, Anderson SY, Lang T. Garlic or jalapeno peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol 1999; 94:1200-1202.